BP
BAK icon

Ballentine Partners’s Braskem BAK Stock Holding History

Ballentine Partners’s Portfolio BAK Stock Details BAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.8K Buy
38,862
+1,726
+5% +$6.52K ﹤0.01% 1055
2026
Q1 		$136K Buy
37,136
+1,532
+4% +$5.8K ﹤0.01% 972
2025
Q4 		$105K Buy
35,604
+21,531
+153% +$59K ﹤0.01% 964
2025
Q3 		$34.1K Buy
+14,073
New +$45.1K ﹤0.01% 1011
2025
Q2 		– Sell
-14,991
Closed -$57.7K – 998
2025
Q1 		$57.7K Buy
+14,991
New +$62.3K ﹤0.01% 879

Other funds holding BAK

RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Ballentine Partners's BAK Position: Q2 2026 in Review

Ballentine Partners increased its Braskem (BAK) stake by 4.6% in Q2 2026, buying an estimated $6.52K and bringing the position to 38,862 shares worth $94.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

Ballentine Partners first reported a position in BAK in Q1 2025 and has held it in 5 quarters since. The position peaked at $136K in Q1 2026. 7 funds tracked by Wall St. Rank hold BAK as of Q2 2026.

  • Ballentine Partners held 38,862 shares of Braskem worth $94.8K as of Q2 2026.
  • Ballentine Partners bought 1,726 Braskem shares in Q2 2026, an estimated $6.52K.
  • Braskem made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #1055 holding.
  • Ballentine Partners first reported a position in Braskem in Q1 2025 and has held it in 5 quarters since.
  • Ballentine Partners's Braskem position peaked at $136K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Braskem as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.